Find clinical trials for Melanoma in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Seattle, WA, USA:
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Seattle, Washington, United States and 37 other locations
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...
Phase 2
Seattle, Washington, United States and 56 other locations
The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC...
Phase 2
Seattle, Washington, United States and 34 other locations
administered to participants with unresectable or metastatic melanoma.The study is divided into two phases: Phase 2 and Phase 3.The primary ...
Phase 2, Phase 3
Seattle, Washington, United States and 19 other locations
artery infusion of SD-101, a TLR 9 agonist, alone or in combination with intravenous checkpoint blockade in adults with metastatic uveal melanoma...
Phase 1
Seattle, Washington, United States and 9 other locations
with relapsed or refractory (R/R) metastatic or locally advanced melanoma, non-small cell lung cancer (NSCLC), and colorectal cancer (CRC)....
Phase 1
Seattle, Washington, United States and 15 other locations
This study will test the safety of a drug called SGN-BB228 in participants with melanoma and other solid tumors that are hard to treat or ha...
Phase 1
Seattle, Washington, United States and 17 other locations
The purpose of this study is to determine whether nivolumab is better than ipilimumab to prevent recurrence of melanoma....
Phase 3
Seattle, Washington, United States and 135 other locations
(PROs) of autogene cevumeran (RO7198457) plus pembrolizumab compared with pembrolizumab alone in patients with previously untreated advanced melanoma...
Phase 2
Seattle, Washington, United States and 56 other locations
is safe and prevents cancer from returning in people with high-risk melanoma. Researchers want to know if V940 with pembrolizumab is better ...
Phase 3
Seattle, Washington, United States and 128 other locations
Clinical trials
Research sites
Resources
Legal